The artificial ovary: current status and future perspectives

Christiani A Amorim1, Ariella Shikanov2

  • 1Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Avenue Mounier 52, bte. B1.52.02, 1200 Brussels, Belgium.

Insights

Researchers are developing transplantable artificial ovaries to restore fertility in cancer survivors at risk of malignant cell transmission from cryopreserved ovarian tissue. This innovative approach aims to mimic the natural ovary for safe fertility preservation.

Area of Science:

  • Biomedical Engineering
  • Reproductive Medicine
  • Oncology

Background:

  • Ovarian tissue cryopreservation is a viable fertility preservation method for cancer patients.
  • Risk of malignant cell transmission from cryopreserved ovarian tissue precludes transplantation in certain cancers.
  • Need for alternative fertility restoration strategies in these high-risk cancer survivors.

Purpose of the Study:

  • To review the progress in developing a transplantable artificial ovary.
  • To discuss the potential of artificial ovaries as a fertility restoration solution.
  • To highlight future trends in artificial ovary development.

Main Methods:

  • Review of current research on artificial ovary construction.
  • Analysis of components required for artificial ovary function: matrix, follicles, and ovarian cells.
  • Discussion of encapsulation and protection strategies for ovarian follicles.

Main Results:

  • Significant advancements have been made in creating functional artificial ovary constructs.
  • Artificial ovaries aim to replicate the natural ovarian microenvironment for follicle development.
  • Key components include biocompatible matrices and essential cellular support systems.

Conclusions:

  • Transplantable artificial ovaries offer a promising alternative for fertility restoration in cancer patients.
  • Further development is needed to fully mimic natural ovarian function and ensure safety.
  • Continued research into biomaterials and cell integration will drive future innovations.

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.5K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.0K
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
3.1K